| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | 17-AAG | CCLE | pan-cancer | AAC | -0.16 | 0.0005 |
| mRNA | RAF265 | CCLE | pan-cancer | AAC | -0.16 | 0.0006 |
| mRNA | narciclasine | CTRPv2 | pan-cancer | AAC | -0.14 | 0.0007 |
| mRNA | GSK2636771 | CTRPv2 | pan-cancer | AAC | 0.18 | 0.0007 |
| mRNA | BI-2536 | CTRPv2 | pan-cancer | AAC | -0.13 | 0.0009 |
| mRNA | FQI-2 | CTRPv2 | pan-cancer | AAC | -0.13 | 0.001 |
| mRNA | BRD-K71935468 | CTRPv2 | pan-cancer | AAC | 0.15 | 0.001 |
| mRNA | GSK461364 | CTRPv2 | pan-cancer | AAC | -0.13 | 0.001 |
| mRNA | nakiterpiosin | CTRPv2 | pan-cancer | AAC | -0.13 | 0.001 |
| mRNA | rigosertib | CTRPv2 | pan-cancer | AAC | -0.13 | 0.001 |